Trial · NCT03323736
Adverse events66
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 66
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Inadequate Anesthesia | Ear and labyrinth disorders | OR Lead-In Cohort (Subjects Treated in OR) | 0 | 68 | 0 |
| other | Inadequate Anesthesia | Ear and labyrinth disorders | Office Lead-In Cohort (Subjects Treated in Office) | 4 | 47 | 4 |
| other | Inadequate Anesthesia | Ear and labyrinth disorders | Pivotal Cohort (Subjects Treated in Office) | 8 | 222 | 8 |
| other | Occluded Tube | Ear and labyrinth disorders | OR Lead-In Cohort (Subjects Treated in OR) | 13 | 68 | 15 |
| other | Occluded Tube | Ear and labyrinth disorders | Office Lead-In Cohort (Subjects Treated in Office) | 5 | 47 | 6 |
| other | Occluded Tube | Ear and labyrinth disorders | Pivotal Cohort (Subjects Treated in Office) | 51 | 222 | 65 |
| other | Otorrhea | Ear and labyrinth disorders | OR Lead-In Cohort (Subjects Treated in OR) | 19 | 68 | 29 |
| other | Otorrhea | Ear and labyrinth disorders | Office Lead-In Cohort (Subjects Treated in Office) | 7 | 47 | 14 |
| other | Otorrhea | Ear and labyrinth disorders | Pivotal Cohort (Subjects Treated in Office) | 60 | 222 | 97 |
| other | Ear Pain | Ear and labyrinth disorders | OR Lead-In Cohort (Subjects Treated in OR) | 6 | 68 | 6 |
| other | Ear Pain | Ear and labyrinth disorders | Office Lead-In Cohort (Subjects Treated in Office) | 9 | 47 | 9 |
| other | Ear Pain | Ear and labyrinth disorders | Pivotal Cohort (Subjects Treated in Office) | 29 | 222 | 32 |
| other | Otitis Media | Ear and labyrinth disorders | OR Lead-In Cohort (Subjects Treated in OR) | 13 | 68 | 25 |
| other | Otitis Media | Ear and labyrinth disorders | Office Lead-In Cohort (Subjects Treated in Office) | 11 | 47 | 14 |
| other | Otitis Media | Ear and labyrinth disorders | Pivotal Cohort (Subjects Treated in Office) | 61 | 222 | 77 |
| other | Upper Respiratory Infection | Respiratory, thoracic and mediastinal disorders | OR Lead-In Cohort (Subjects Treated in OR) | 9 | 68 | 12 |
| other | Upper Respiratory Infection | Respiratory, thoracic and mediastinal disorders | Office Lead-In Cohort (Subjects Treated in Office) | 3 | 47 | 3 |
| other | Upper Respiratory Infection | Respiratory, thoracic and mediastinal disorders | Pivotal Cohort (Subjects Treated in Office) | 18 | 222 | 21 |
| other | Acute Sinusitis | Respiratory, thoracic and mediastinal disorders | OR Lead-In Cohort (Subjects Treated in OR) | 4 | 68 | 4 |
| other | Acute Sinusitis | Respiratory, thoracic and mediastinal disorders | Office Lead-In Cohort (Subjects Treated in Office) | 1 | 47 | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03323736/events